Not recruiting
Human papilloma virus immunisation
Not recruitingRegistered drugNo placebo
Study on the Safety and Immune Response of 9vHPV Vaccine in Preventing HPV in Boys and Girls Aged 9-14 Compared to Young Women Aged 16-26
Registered drugNo placebo
- Disease:Human papilloma virus immunisation
- Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By RdnaHuman Papillomavirus Type 16 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna+7
Countries:
Poland
Poland- Participants:0–17 years · 18–64 years · Healthy volunteers
- Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
- Sponsor:Merck Sharp & Dohme LLC
